Vibrant

Vibrant is a leading AI-driven large molecule drug discovery company founded in 2019 by a team of seasoned antibody drug engineering and computational scientists. The company’s team possesses deep expertise in large molecule drug development along with exclusive advantages in engineering development data. Its innovative target discovery platform and cutting-edge algorithm platforms for antibody structure and engineering have achieved breakthroughs across generations. Vibrant is currently focused on unmet medical needs within areas such as cancer immunotherapy, with multiple projects already yielding positive biological validation data.